Baseline concentrations of radionuclides and heavy metals in soils and vegetation around the DARHT facility: Construction phase (1996)

As part of the Department of Energy`s Mitigation Action Plan for the Dual Axis Radiographic Hydrodynamic Test (DARHT) Facility at Los Alamos National Laboratory (LANL), baseline concentrations of radionuclides ({sup 3}H, {sup 137}Cs, {sup 90}Sr, {sup 238}Pu, {sup 239}Pu, {sup 241}Am, total U), and heavy metals (Ag, As, Ba, Be, Cd, Cr, Cu, Hg, Ni, Pb, Sb, Se and Tl) in soil, sediment, and vegetation (overstory and understory) around the DARHT facility during the construction phase in 1996 were determined. Also, U and Be concentrations in soil samples collected in 1993 from within the proposed DARHT facility area are reported. Most radionuclides in soils, sediments, and vegetation were within current background and/or long-term regional statistical reference levels

Radionuclide concentrations in pinto beans, sweet corn, and zucchini squash grown in Los Alamos Canyon at Los Alamos National Laboratory

Pinto beans, sweet corn, and zucchini squash (Cucurbita pepo var. black beauty) were grown in a randomized complete-block field/pot experiment at a site that contained the highest observed levels of surface gross gamma radioactivity within Los Alamos Canyon (LAC) at Los Alamos National Laboratory. Soils as well as washed edible and nonedible crop tissues were analyzed for various radionuclides and heavy metals . Most radionuclides, with the exception of {sup 3}H and {sup tot}U, in soil from LAC were detected in significantly higher concentrations (p <0.01) than in soil collected from regional background (RBG) locations. Similarly, most radionuclides in edible crop portions of beans, squash, and corn were detected in significantly higher (p <0.01 and 0.05) concentrations than RBG. Most soil-to-plant concentration ratios for radionuclides in edible and nonedible crop tissues from LAC were within the default values given by the Nuclear Regulatory Commission and Environmental Protection Agency. All heavy metals in soils, as well as edible and nonedible crop tissues grown in soils from LAC, were within RBG concentrations. Overall, the total maximum net positive committed effective dose equivalent (CEDE)--the CEDE plus two sigma for each radioisotope minus background and then all positive doses summed--to a hypothetical 50-year resident that ingested 160 kg of beans, corn, and squash in equal proportions, was 74 mrem y{sup -1}. This dose was below the International Commission on Radiological Protection permissible dose limit (PDL) of 100 mrem y{sup -1} from all pathways; however, the addition of other internal and external exposure route factors may increase the overall dose over the PDL. Also, the risk of an excess cancer fatality, based on 74 mrem y{sup -1}, was 3.7 x 10{sup -5} (37 in a million), which is above the Environmental Protection Agency`s (acceptable) guideline of one in a million. 31 refs., 15 tabs

Cholestatic hepatitis as a possible new side-effect of oxycodone: a case report

<p>Abstract</p> <p>Introduction</p> <p>Oxycodone is a widely-used semisynthetic opioid analgesic that has been used for over eighty years. Oxycodone is known to cause side effects such as nausea, pruritus, dizziness, constipation and somnolence. As far as we are aware cholestatic hepatitis as a result of oxycodone use has not been reported so far in the world literature.</p> <p>Case presentation</p> <p>A 34-year-old male presented with cholestatic jaundice and severe pruritus after receiving oxycodone for analgesia post-T11 vertebrectomy. Extensive laboratory investigations and imaging studies did not reveal any other obvious cause for his jaundice and a liver biopsy confirmed canalicular cholestatis suggestive of drug-induced hepatotoxicity. The patient's symptoms and transaminases normalised on withdrawal of oxycodone confirming that oxycodone was the probable cause of the patient's hepatotoxicity.</p> <p>Conclusion</p> <p>We conclude that cholestatic hepatitis is possibly a rare side effect of oxycodone use. Physicians should be aware of the possibility of this potentially serious picture of drug-induced hepatotoxicity.</p

Life-threatening acute acalculous cholecystitis in a patient with renal cell carcinoma treated by sunitinib: a case report

<p>Abstract</p> <p>Introduction</p> <p>Sunitinib, an oral multitargeted tyrosine kinase inhibitor, is widely used in the treatment of renal cell carcinoma and gastrointestinal stromal tumor and has had a variety of adverse events. However, sunitinib-related acute cholecystitis has been reported in only two patients with gastrointestinal stromal tumor and renal cell carcinoma (clear cell subtype).</p> <p>Case presentation</p> <p>A 75-year-old Japanese woman with a right sided abdominal swelling was referred to our hospital. Computed tomography (CT) showed a hypervascular bulky tumor in her right kidney, suggesting right renal cell carcinoma in clinical T4N0M0. Although sunitinib therapy was started as neoadjuvant chemotherapy, during the fourth week of the first cycle, she developed acute acalculous cholecystitis and disseminated intravascular coagulation associated with sunitinib. Sunitinib therapy was discontinued immediately and she recovered after subsequent treatment with antibiotics and gabexate mesilate followed by percutaneous cholecystostomy. Cholecystectomy and right radical nephrectomy were performed and pathological examination showed that her renal tumor was a chromophobe renal cell carcinoma (pT2) with necrosis. Inflammation and ischemia were observed in the gallbladder wall, which was compatible with acute acalculous cholecystitis. There has been no evidence of disease recurrence for more than six months.</p> <p>Conclusion</p> <p>We described the third case of sunitinib-related acute cholecystitis in a patient with chromophobe renal cell carcinoma. Attention is required to sunitinib-related acute cholecystitis which, while uncommon, could be life-threatening.</p

Dynamics of Rye Chromosome 1R Regions with High or Low Crossover Frequency in Homology Search and Synapsis Development

In many organisms, homologous pairing and synapsis depend on the meiotic recombination machinery that repairs double-strand DNA breaks (DSBs) produced at the onset of meiosis. The culmination of recombination via crossover gives rise to chiasmata, which locate distally in many plant species such as rye, Secale cereale. Although, synapsis initiates close to the chromosome ends, a direct effect of regions with high crossover frequency on partner identification and synapsis initiation has not been demonstrated. Here, we analyze the dynamics of distal and proximal regions of a rye chromosome introgressed into wheat to define their role on meiotic homology search and synapsis. We have used lines with a pair of two-armed chromosome 1R of rye, or a pair of telocentrics of its long arm (1RL), which were homozygous for the standard 1RL structure, homozygous for an inversion of 1RL that changes chiasma location from distal to proximal, or heterozygous for the inversion. Physical mapping of recombination produced in the ditelocentric heterozygote (1RL/1RLinv) showed that 70% of crossovers in the arm were confined to a terminal segment representing 10% of the 1RL length. The dynamics of the arms 1RL and 1RLinv during zygotene demonstrates that crossover-rich regions are more active in recognizing the homologous partner and developing synapsis than crossover-poor regions. When the crossover-rich regions are positioned in the vicinity of chromosome ends, their association is facilitated by telomere clustering; when they are positioned centrally in one of the two-armed chromosomes and distally in the homolog, their association is probably derived from chromosome elongation. On the other hand, chromosome movements that disassemble the bouquet may facilitate chromosome pairing correction by dissolution of improper chromosome associations. Taken together, these data support that repair of DSBs via crossover is essential in both the search of the homologous partner and consolidation of homologous synapsis

Multiband electronic characterization of the complex intermetallic cage system Y1−xGdxCo2Zn20

ABSTRACT: FeGa3 is an unusual intermetallic semiconductor that presents intriguing magnetic responses to the tuning of its electronic properties. When doped with Ge, the system evolves from diamagnetic to paramagnetic to ferromagnetic ground states that are not well understood. In this work, we have performed a joint theoretical and experimental study of FeGa3−xGex using density functional theory and magnetic susceptibility measurements. For low Ge concentrations we observe the formation of localized moments on some Fe atoms and, as the dopant concentration increases, a more delocalized magnetic behavior emerges. The magnetic configuration strongly depends on the dopant distribution, leading even to the appearance of antiferromagnetic interactions in certain configurations

Association between isotretinoin use and central retinal vein occlusion in an adolescent with minor predisposition for thrombotic incidents: a case report

<p>Abstract</p> <p>Introduction</p> <p>We report an adolescent boy with minimal pre-existing risk for thromboses who suffered central retinal vein occlusion associated with isotretinoin use for acne. To the best of our knowledge, this is the first well documented case of this association.</p> <p>Case presentation</p> <p>An otherwise healthy 17-year-old white man who was treated with systemic isotretinoin for recalcitrant acne was referred with central retinal vein occlusion in one eye. Although a detailed investigation was negative, DNA testing revealed that the patient was a heterozygous carrier of the G20210A mutation of the prothrombin gene. Despite the fact that this particular mutation is thought to represent only a minor risk factor for thromboses, it is probable that isotretinoin treatment greatly increased the risk of a vaso-occlusive incident in this patient.</p> <p>Conclusion</p> <p>Isotretinoin use may be associated with sight- and life-threatening thrombotic adverse effects even in young patients with otherwise minimal thrombophilic risk. Physicians should be aware of such potential dangers.</p